Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
16%
Acute Myeloid Leukemia
50%
Anticoagulant Agent
5%
Apoptosis
14%
Artery Thrombosis
50%
Biological Marker
16%
Bosutinib
14%
Cause of Death
5%
Cell Death
7%
Cell Proliferation
7%
Cell Viability
7%
Chronic Myeloid Leukemia
50%
Circulating microRNA
16%
Clinical Study
50%
Dasatinib
28%
Diffuse Large B Cell Lymphoma
50%
Diseases
5%
Eculizumab
50%
Endothelial Dysfunction
7%
Flow Cytometry
5%
Hemolysis
7%
Imatinib
7%
Malignant Neoplasm
33%
microRNA
50%
microRNA 20a
16%
Monoclonal Antibody
5%
Multidrug Resistance Protein 1
50%
Multiple Drug Resistance
50%
Necrosis
14%
Nilotinib
28%
Nucleic Acid
16%
Paroxysmal Nocturnal Hemoglobinuria
50%
Phosphatidylserine
6%
Phospholipid
16%
Ponatinib
42%
Procoagulant
50%
Promyelocytic Leukemia
16%
Protein
5%
Protein Tyrosine Kinase Inhibitor
50%
Relapse
16%
Remission
18%
Remission
7%
Salicylate Sodium
6%
Survival
7%
Thrombin
22%
Thromboembolism
5%
Toxicity
14%
Wound
7%
Medicine and Dentistry
Acute Leukemia
8%
Acute Myeloid Leukemia
50%
Acute Promyelocytic Leukemia
8%
Analysis
10%
Assay
70%
Biological Marker
8%
Blood Component
8%
Cancer Cell
16%
Cell Line
8%
Cells
33%
Circulating microRNA
8%
Complication
8%
Donor
10%
Drug Resistance
41%
Erythrocyte
35%
Erythrocyte Concentrate
100%
Erythrocyte Transfusion
8%
Flow Cytometry
8%
Hemolysis
8%
HL60
50%
Immune Response
10%
In Vitro
10%
Laboratory
10%
Leukemia Cell
50%
microRNA
50%
microRNA 20a
8%
Multidrug Resistance
50%
Multidrug Resistance Protein 1
25%
Nucleic Acid
8%
Patient
10%
Phospholipid
16%
Procoagulant
50%
Relapse
8%
Spectrophotometry
8%
Therapeutic Procedure
8%
Thrombin
35%
Transfusion
10%
Nursing and Health Professions
Cause of Death
6%
Eculizumab
50%
Erythrocyte Concentrate
50%
Erythrocyte Preservation
10%
Flow Cytometry
12%
Hemolysis
6%
Paroxysmal Nocturnal Hemoglobinuria
50%
Pathophysiology
50%
Phosphatidylserine
6%
Procoagulant
18%
Salicylate Sodium
6%
Thrombocyte Free Plasma
18%
Thromboembolism
6%
Thromboplastin
6%
Thrombus
6%